Magellan Health Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Magellan Health (MGLN) Tops Q3 EPS by 8c, Revenues Beat; Lowers FY18 EPS Guidance Below Consensus, Affirms FY18 Revenue Outlook
November 7, 2018 6:32 AM ESTMagellan Health (NASDAQ: MGLN) reported Q3 EPS of $1.45, $0.08 better than the analyst estimate of $1.37. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.85 billion.
Net revenue increased 31 percent over the third quarter of 2017 to $1.9 billion.Net income decreased 16 percent over the third quarter of 2017 to $27.1... More